| 000 | 01646 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517162109.0 | ||
| 264 | 0 | _c20180406 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1756-9966 | ||
| 024 | 7 |
_a10.1186/s13046-017-0561-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYe, Ruisong | |
| 245 | 0 | 0 |
_aCRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model. _h[electronic resource] |
| 260 |
_bJournal of experimental & clinical cancer research : CR _c06 2017 |
||
| 300 |
_a90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCRISPR-Cas Systems |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xgenetics |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Editing |
| 650 | 0 | 4 | _aGene Order |
| 650 | 0 | 4 | _aGene Targeting |
| 650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xchemistry |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aPi, Min | |
| 700 | 1 | _aCox, John V | |
| 700 | 1 | _aNishimoto, Satoru K | |
| 700 | 1 | _aQuarles, L Darryl | |
| 773 | 0 |
_tJournal of experimental & clinical cancer research : CR _gvol. 36 _gno. 1 _gp. 90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13046-017-0561-x _zAvailable from publisher's website |
| 999 |
_c27320774 _d27320774 |
||